New Data Suggest COVAXIN™ (BBV152) Vaccine Candidate Generates Robust Immune Memory to COVID-19 and Variants of Concern for At Least Six Months After Vaccination
https://finance.yahoo.com/news/data-sugg...00779.html
https://finance.yahoo.com/news/data-sugg...00779.html